Patents Assigned to Dainippon Pharmaceutical Co., Ltd.
  • Patent number: 3988456
    Abstract: 1,2-Diphenylethanolamine derivatives of the formula: ##SPC1##Wherein R.sub.1 and R.sub.2 are each hydrogen, a halogen, nitro, hydroxy, an alkyl or methoxy; R.sub.3 is a group of the formula: ##SPC2##Wherein R.sub.4, R.sub.5 and R.sub.6 are each hydrogen, a halogen or methoxy and n is an integer of 0 to 3, or a pyridyl; and Z is hydroxy or an acyloxy; with proviso that when R.sub.1 and/or R.sub.2 are hydroxy, Z is hydroxy, and their pharmaceutically acceptable salts, which have excellent analgesic and anti-tussive activities, and a process for the preparation thereof.
    Type: Grant
    Filed: March 24, 1975
    Date of Patent: October 26, 1976
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Haruki Nishimura, Hitoshi Uno, Kagayaki Natsuka, Noriaki Shimokawa, Masanao Shimizu, Hideo Nakamura
  • Patent number: 3986930
    Abstract: A reagent for determining lipase activity, which comprises as the active ingredient one of the S-acyl compounds of the formula: ##EQU1## WHEREIN N IS AN INTEGER OF 2 TO 4, INCLUSIVE; N' IS AN INTEGER OF 2 TO 4, INCLUSIVE OR OF 9 TO 13, INCLUSIVE; M IS AN INTEGER OF 3, 7 OR 11; M' IS AN INTEGER OF 4 OR 12; Y IS AN INTEGER OF 1 OR 2; X is sulfur atom or oxygen atom; Y is sulfur atom, oxygen atom or ethylene group; provided that when y is 1, m' is 4 and when y is 2, m' is 12, and a method for determining lipase activity by reacting the S-acyl compound with lipase in a buffer solution containing a chromogenic sulfhydryl reagent and then subjecting the resultant to a colorimetry.
    Type: Grant
    Filed: May 22, 1975
    Date of Patent: October 19, 1976
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Shigeru Kurooka, Masahisa Hashimoto, Masatsugu Tomita, Akio Maki
  • Patent number: 3985869
    Abstract: An enzyme being capable of lysing cells of dental caries-inducing microorganisms and a method for producing the same by cultivating a microorganism belonging to the genus Streptomyces, especially wild type strains of Streptomyces diastatochromogenes, Streptomyces farinosus, Streptomyces globisporus and Streptomyces griseus var. H-402, compositions for preventing and treating dental caries containing the said enzyme and methods for preventing and treating dental caries.
    Type: Grant
    Filed: April 22, 1975
    Date of Patent: October 12, 1976
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Yoshio Yoshimura, Kanae Yokogawa, Shigeo Kawata
  • Patent number: 3985875
    Abstract: New .omega.-(N-acylamino)alkylphosphoryl ethanolamines and their pharmaceutically acceptable acid addition salts have superior renin-inhibitory activities, antihypertensive activities and cholesterol-lowering activities. The .omega.-(N-acylamino)alkylphosphoryl ethanolamines are prepared by (1) reacting an .omega.-(N-acylamino) alkanol with a 2-(N-substituted amino)ethyl phosphate or its derivative, hydrolyzing the resulting product or splitting off the phosphoric acid-protective group of the resulting product thereby to form an .omega.-(N-acylamino) alkyl 2-(N-substituted amino) ethyl phosphate, and splitting off the amino-protective groups of the resulting phosphate, or (2) reacting an .omega.-(N-acylamino) alkanol with a phosphorus oxyhalide, reacting the resulting .omega.-(N-acylamino)alkyl dichlorophosphate with a 2-(N-substituted amino) ethanol, hydrolyzing the reaction product to form an .omega.
    Type: Grant
    Filed: December 30, 1974
    Date of Patent: October 12, 1976
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Kouji Hayashi, Masahisa Hashimoto, Kiyoshi Nakamura, Masanao Shimizu, Naonobu Hatano, Kunihiko Takeyama
  • Patent number: 3983239
    Abstract: Hexahydro-.gamma.-carboline derivatives of the formula: ##SPC1##Wherein R.sub.1 is methyl or ethyl, and R.sub.2 is hydrogen, methyl or ethyl, with proviso that when R.sub.1 is ethyl, R.sub.2 is hydrogen, and their pharmaceutically acceptable acid addition salts, which exhibit excellent psychotropic effect, and a process for the preparation thereof.
    Type: Grant
    Filed: March 12, 1975
    Date of Patent: September 28, 1976
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Yasutaka Nagai, Hitoshi Uno, Masanao Shimizu, Tadahiko Karasawa
  • Patent number: 3981999
    Abstract: Pyrimidine compositions or their non-toxic acid-addition salts are used for preventing and treating infectious diseases of fish caused by pathogenic microorganisms.
    Type: Grant
    Filed: October 10, 1974
    Date of Patent: September 21, 1976
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Masanao Shimizu, Yoshiyuki Takase, Kaoru Kouno
  • Patent number: 3962443
    Abstract: This invention provides compounds of the following formula ##SPC1##Wherein R.sub.1 is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, a hydroxyalkyl group having 2 to 4 carbon atoms, a benzyl group, a benzyl group subsituted by methoxy, a phenyl group, a propargyl group or an acyl group; R.sub.2 is hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkyl group having 2 to 4 carbon atoms substituted by hydroxy or halogen, a vinyl group, an allyl group, or a benzyl group R.sub.3 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms;And salts thereof, and processes for preparing them. Some of the compounds have antibacterial activities.
    Type: Grant
    Filed: February 21, 1975
    Date of Patent: June 8, 1976
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Shinsaku Minami, Jun-ichi Matsumoto, Kazuyo Kawaguchi, Shinsaku Mishio, Masanao Shimizu, Yoshiyuki Takase, Shinichi Nakamura
  • Patent number: 3957788
    Abstract: 1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives of the formula: ##SPC1##Wherein X is hydroxy, methoxy, methyl or trifluoromethyl; and R is an unsubstituted monocycloalkyl group having 6 to 8 carbon atoms or 2-methoxyphenyl; provided that when X is hydroxy, R is cyclohexyl, and when X is trifluoromethyl, R is 2-methoxyphenyl,And their pharmaceutically acceptable salts, which have excellent analgesic, anti-tussive and anti-inflammatory activities, without undesirable side effect such as narcotic activity, and a process for the preparation thereof.
    Type: Grant
    Filed: January 15, 1975
    Date of Patent: May 18, 1976
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Haruki Nishimura, Hitoshi Uno, Kagayaki Natsuka, Noriaki Shimokawa, Masanao Shimizu, Hideo Nakamura
  • Patent number: 3948928
    Abstract: 3-Substituted-1,2-benzisoxazole derivative of the following formula: ##SPC1##Wherein R.sub.1 is hydrogen, hydroxy, nitro, alkyl, alkoxy, halogen or amino; R.sub.2 is hydroxyamino, amino, hydrazino, mono- or di- alkyl substituted amino, aralkylamino, acyloxyamino, morpholino, piperazine which is unsubstituted or substituted with alkyl, aralkyl or aryl at 4 position, or pyrrolidino, or R.sub.2 may combine with imino group and form together with the adjacent carbon atom a heterocyclic ring such as imidazoline or tetrahydropyrimidine; and n is an integer of 0 to 3, and its pharmaceutically acceptable acid addition salt, and preparation thereof. The present compounds show valuable pharmacological properties, such as anti-reserpine activity, central nervous depressing activity, anti-hypertensive activity and l-dopa potentiating activity.
    Type: Grant
    Filed: March 12, 1973
    Date of Patent: April 6, 1976
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Haruki Nishimura, Masanao Shimizu, Hitoshi Uno, Tetsuo Hirooka, Yoshinobu Masuda, Mikio Kurokawa
  • Patent number: 3935268
    Abstract: .omega.-[Bis(.omega.,.omega.-diphenylalkyl)amino]alkan-1-ol having the following formula: ##SPC1##And their pharmaceutically acceptable acid addition salts which are useful for preventing and treating cerebral vascural diseases caused by cerebral blood flow disorder, processes for preparing the compounds and pharmaceutical compositions containing the compound.
    Type: Grant
    Filed: August 30, 1972
    Date of Patent: January 27, 1976
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Hidehiko Kaneko, Jiro Aritomi, Yuzuru Yamato, deceased